• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

CVS Health Inks Larger PBM Contract with Federal Employee Program, Adds Specialty Pharmacy Care

by Fred Pennic 03/31/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
CVS Health Launches Transform Oncology Care Program, Partners with Tempus

What You Should Know:

– Today, CVS Caremark, the Pharmacy Benefit Manager (PBM) of CVS Health announced a larger PBM contract with the Government-wide Service Benefit Plan (also known as the Federal Employee Program), which has provided benefits to the federal workforce for 60 years and covers 5.5 million employees, retirees and their families. CVS Health has been the pharmacy benefit manager for the Service Benefit Plan since 1993 and has partnered with them to provide and evolve the pharmacy services their members need over the many years.

– With the new contract effective Jan. 1, 2022, CVS Health regained the specialty pharmacy business – which was lost in 2018 – while also retaining the mail, retail and clinical pharmacy services in the current contract. This allows CVS Health to deliver greater cost savings and better care to the Service Benefit Plan and its members with specialty once again integrated with pharmacy services. As you well know, specialty is the biggest growth area in pharmacy spend so it’s critical to manage – and well.

– Integrated management of specialty and traditional pharmacy services also means CVS Health can help the Service Benefit Plan effectively manage spend by cutting cost and wasteful spend every step of the process. Their clinically rigorous therapy decisions and high-touch clinical engagement also helps ensure the right therapies are being used at the right time for the right patients, ultimately improving outcomes.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: CVS Health, Pharmacy

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

The AI Paradox in Healthcare: Notable CEO Shares Why Moving Too Slowly is a Greater Risk

Most-Read

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Patient Square Capital Acquires Premier in $2.6B Deal

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |